New call-to-action
New call-to-action
New call-to-action

FPWR Blog

Jessica Bohonowych

Jessica Bohonowych is a graduate of Duke University, and holds a PhD in Pharmacology and Toxicology at the University of California, Davis. Incorporating her research background, knowledge of pharmacology and drug development, and teaching experience, Jessica works with Theresa Strong in managing FPWR’s grant portfolio, communicating research results and breakthroughs to our community, aiding in special projects such as the Clinical Trials Initiative and Molecular Resource Center, and is heading the development of the Global PWS Registry.

Recent Posts

Are there benefits to testosterone replacement therapy in adult males with PWS?

One well established characteristic of PWS is altered development and function of reproductive systems. This can include hypogonadism; under-development of sexual organs, particularly the testes in males; precocious puberty; and infertility.

Topics: Research

New Study Examines How Drugs Can Regulate Gene Expression. Important Steps Toward Reactivating the Maternal Allele

“Isn’t there a way to just ‘turn on’ the silent PWS genes on chromosome 15?” It's a common question amongst the PWS community. The PWS genes on the maternal chromosome 15 are present but silenced in all people with PWS, regardless of genetic subtype.

Topics: Research

Skin Picking In PWS: An Overview of Incidence and Therapies

It is well accepted that self injurious skin picking is a major struggle among those with PWS, and is an upsetting challenge for parents and caregivers as well. However, there are few studies in this area and statistics are lacking regarding the freq...

Topics: Research

From discovery to therapeutic...learning about the FDA process

Knowlege is empowering! For those who are interested in learning more about the drug discovery and approval process, the FDA (Federal Drug Administration) has a new informational website directed specifically at patient education and involvement.

Topics: Research

Targeting serotonin for PWS

In a recent email correspondence, Dr. Cunningham at the University of Texas Medical Branch thanked FPWR and described the contribution that FPWR grant funds (2010-2011) have had on the work coming out of her laboratory. She writes, "thank you for the...

Topics: Research

Central adrenal insufficiency (CAI) in PWS: update on prevalence and potential effects

An FPWR blog in September 2009 highlighted research into the potential role of central adrenal insufficiency (CAI) in cases of sudden and unexpected death in PWS patients. Some recent studies provide more information on the prevalence of CAI in PWS a...

Topics: Research

Oral Health in PWS

This blog was coauthored by Jessica Bohonowych and Theresa Strong

Topics: Research

Long-Term Safety and Benefits of Growth Hormone Therapy for PWS

Several new reports on growth hormone (GH) therapy support the benefits of GH use in PWS, while continuing the trend of a reassuring safety profile.

Topics: Research

Peptide YY and Obesity: A Promising New Examination

Obese individuals often have a deficiency in peptide YY (PYY), a hormone that is produced by endocrine "L" cells of the lower gastrointestinal tract, the stomach and the brainstem. Low levels of PYY may be a predisposing factor to the development of ...

Topics: Research